Selective laser trabeculoplasty versus argon laser trabeculoplasty: Results from a 1-year randomised clinical trial

K. F. Damji, A. M. Bovell, W. G. Hodge, W. Rock, K. Shah, R. Buhrmann, Y. I. Pan

Research output: Contribution to journalArticlepeer-review

151 Citations (Scopus)

Abstract

Aims: To compare selective laser trabeculoplasty (SLT) and argon laser trabeculoplasty (ALT), in terms of intraocular pressure (IOP) lowering, in patients with open-angle glaucoma. Methods: 176 eyes of 152 patients were enrolled in this study, 89 in the SLT and 87 in the ALT groups. Patients were randomised to receive either SLT or ALT treatment to 180° of the trabecular meshwork. Patients were followed up to 12 months after treatment. The main outcome measured was IOP lowering at 12 months after treatment, compared between the SLT and ALT groups. Results: No significant difference (p = 0.846) was found in mean decrease in IOP between the SLT (5.86 mm Hg) and ALT (6.04 mm Hg) groups at 1 year or at any other time points, nor were there any significant differences in the rate of early or late complications between the two groups. Conclusions: SLT is equivalent to ALT in terms of IOP lowering at 1 year, and is a safe and effective procedure for patients with open-angle glaucoma.

Original languageEnglish
Pages (from-to)1490-1494
Number of pages5
JournalBritish Journal of Ophthalmology
Volume90
Issue number12
DOIs
Publication statusPublished - Dec 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Selective laser trabeculoplasty versus argon laser trabeculoplasty: Results from a 1-year randomised clinical trial'. Together they form a unique fingerprint.

Cite this